HIV treatment in African Americans: Challenges and opportunities

Journal of Black Psychology

Volumn 30, Issue 1, 2004, Pages 24-39

  Cargill, Victoria A ^a   Stone, Valerie E ^b   Robinson, M Renee ^c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

African Americans; HIV treatment

Indexed keywords

EID: 14244265969     PISSN: 00957984     EISSN: 15524558     Source Type: Journal    
DOI: 10.1177/0095798403259243     Document Type: Article

References (61)

1. Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A., et al. (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17, 377-381.
2. Bing, E. G., Burnam, M. A., Longshore, D., Fleishman, J. A., Sherbourne, C. D., London, A. S., et al. (2001). Psychiatric disorders and drug use among HIV infected adults in the U.S. Archives of General Psychiatry, 58, 721-728.
3. Bogart, L. M., Catz, S. L., Kelly, J. A., & Benotsch, E. G. (2001). Factors influencing physicians' judgments of adherence and treatment decisions for patients with HIV disease. Medical Decision Making, 21, 28-36.
4. Bozzette, S. A., Berry, S. H., Duan, N., Frankel, M. R., Leibowitz, A. A., Lefkowitz, D., et al. (1998). The care of HIV-infected adults in the United States. New England Journal of Medicine, 339(26), 1897-1904.
5. Brown, L. S. (1990). Taking account of gender in the clinical assessment interview. Professional Psychology: Research and Practice, 21(1), 12-17.
6. Burack, J. H., & Barrett, D. C. (1993). Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. Journal of the American Medical Association, 270, 2568-2573.
7. Centers for Disease Control and Prevention. (2002a). Fact sheet: HIV/AIDS among African-Americans. Retrieved March 11, 2002, from http://www.cdc.gov/ nchstp/od/news/At-a-Glance.pdf
8. Centers for Disease Control and Prevention. (2002b). HIV/AIDS surveillance report, 13(2), 1-44. Retrieved December 29, 2002, from http://www.cdc.gov/hiv/pubs/Facts/afam.htm
9. Chaisson, R. E., Keruly, J. C., & Moore, R. D. (1995). Race, sex, drug use, and progression of HIV disease. New England Journal of Medicine, 333(12), 751-756.
10. Corbie-Smith, G., Thomas, S. B., & St. George, D. M. M. (2002). Distrust, race, and research. Archives of Internal Medicine, 162, 2458-2463.
11. Crepaz, N., & Marks, G. (2002). Towards an understanding of sexual risk behavior in people living with HIV: A review of social, psychological, and medical findings. AIDS, 25, 135-149.
12. Dean, C., Antoni, M. H., Schneiderman, N., Ironson, G., McCabe, P., Fernandez, J. B., et al. (2000). Cognitive-behavioral stress management increases free testosterone and decreases psychological distress in HIV-seropositive men. Health Psychology, 19(1), 12-20.
13. DHHS Treatment Guidelines (2003). Retrieved July 13 2003, from, http://www.aidsinfo.nih.gov.
14. Diamant, A. L., Schuster, M. A., McGuigan, K., & Lever, J. (1999). Lesbians' sexual history with men: Implications for taking a sexual history. Archives of Internal Medicine, 159(22), 2730-2736.
15. Dilorio, C., Hartwell, T., & Hansen, N. (2002). Childhood sexual abuse and high risk behaviors among men at high risk for HIV infection. American Journal of Public Health, 92(2), 214-219.
16. Estrada, A. L. (2002). Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users. Public Health Reports, 117(Suppl. 1), S126-S134.
17. Galea, S., & Vlahov, D. (2002). Social determinants and the health of drug users: Socioeconomic status, homelessness, and incarceration. Public Health Reports, 117(Suppl. 1), S135-S145.
18. Gant, L. M., Green, W., Stewart, P. A., Wheeler, D. P., & Wright, E. M. (1998). HIV/AIDS and African Americans: Assumptions, myths, and realities. In L. M. Gant, P. A. Stewart, & V J. Lynch (Eds.), Social workers speak out on the HIV/AIDS crisis (pp. 1-12). Westport, CT: Praeger.
19. Gifford, A. L., Cunningham, W. E., & Heslin, K. C. (2002). Participation in research and access to experimental treatments by HIV-infected patients. New England Journal of Medicine, 346, 1373-1382.
20. Heckman, T. G. (2003). The chronic illness quality of life (CIQOL) model: Explaining life satisfaction in people living with HIV disease. Health Psychology, 22, 140-147.
21. Heckman, T. G., Kochman, A., Sikkema, K. J., Kalichman, S. C., Masten, J., & Goodkin, K. (2000). Late middle-aged and older men living with HIV/AIDS: Race differences in coping, social support, and psychological distress. Journal of the National Medical Association, 92, 436-444.
22. Herbert, T. B., & Cohen, S. (1993). Depression and immunity: A meta-analytic review. Psychological Bulletin, 113, 472-486.
23. Hsu, L., Vittinghoff, E., Katz, M. H., & Schwarcz, S. K. (2001). Predictors of use of highly-active antiretroviral therapy (HAART) among persons with AIDS in San Francisco 1996-1999. Journal of Acquired Immunodeficiency Syndrome, 28, 345-350.
24. Ickovics, J. R., Hamburger, M. E., Vlahov, D., Schoenbaum, E. E., Schuman, P., Boland, R. J., et al. (2001). Mortality, CD4 cell count decline, and depressive symptoms among HIV- seropositive women: Longitudinal analysis from the HIV epidemiology research study. Journal of the American Medical Association, 285(11), 1466-1474.
25. Jeffe, D. B., Khan, S. R., Meredith, K. L., Schlesinger, M., Fraser, V J., & Mundy, L. M. (2000). Disclosure of HIV status to medical providers: Differences by gender, "race" and immune function. Public Health Reports, 115, 38-45.
26. Jones, D. J., Beach, S. R. H., & Forehand. R. (2001). Disease status in African-American single mothers with HIV: The role of depressive symptoms. Health Psychology, 20(6), 417-423.
27. Kalichman, S. C., Kelly, J. A., Hunter, T. L., Murphy, D. A., & Tyler, R. (1993). Culturally tailored HIV-AIDS risk-reduction messages targeted to African-American urban women: Impact on risk sensitization and risk reduction. Journal of Consulting and Clinical Psychology, 61(2), 291-295.
28. Kalichman, S. C., Ramachandran, B., & Catz, S. (1999). Adherence to combination antiretroviral therapies in HIV patients of low health literacy. Journal of General Internal Medicine, 14, 267-273.
29. Kottiri, B. J., Friedman, S. R., Neaigus, A., Curtis, R., & Des Jarlais, D. C. (2002). Risknetworks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. Journal of Acquired Immune Deficiency Syndrome, 30, 95-104.
30. Leserman, J., Perkins, D. O., & Evans, D. L. (1992). Coping with the threat of AIDS: The role of social support. American Journal of Psychiatry, 149(11), 1514-1520.
31. Lichenstein, B. (2000). Secret encounters: Black men, bisexuality, and AIDS in Alabama. Medical Anthropology Quarterly, 14(3), 374-393.
32. Logan, T. K., Cole, J., & Leukefeld, C. (2002). Women, sex and HIV: Social and contextual factors, meta-analysis of published interventions, implications for practice and research. Psychological Bulletin, 128(6), 851-885.
33. MacDonald, B. J. (1998). Issues in therapy with gay and lesbian couples. Journal of Sexual and Marital Therapy, 24(3), 165-190.
34. Malcolm, S. E., Ng, J. J., Rosen, R. K., & Stone, V E. (2003). An examination of patients who have excellent adherence to HAART AIDS Care, 15, 251-261.
35. Marrazzo, J. M., Koutsky, L. A., & Handsfield, H. H. (2001). Characteristics of female sexually transmitted disease clinic clients who report same-sex behavior. International Journal of Sexually Transmitted Diseases and AIDS, 12(1), 41-46.
36. Mtty, J. A., Stone, V E., Sands, M., Macalino, G., & Flanigan, T. (2002). Directly observed therapy for the treatment of people with human immunodeficiency virus infection: A work in progress. Clinical Infectious Diseases, 34, 984-990.
37. Moore, J., Schuman, P., Schoenbaum, E. E., Boland, B., Solomon, L., & Smith, D. K. (1999). Severe life events and depressive symptoms among with or at risk for HIV infection in four cities in the USA. AIDS, 13, 2459.
38. Moore, R., Stanton, D., Gopalan, R., & Chaisson, R. E. (1994). Racial differences in the use of drug therapy for HIV disease in an urban community. New England Journal of Medicine, 330(11), 763-768.
39. Mor, V., Fleishman, J. A., Dresser, M., & Piette, J. (1992). Variation in health service among HIV infected patients. Medical Care, 30(1), 17-29.
40. Mostashari, F., Riley, E., Selwyn, P. A., & Altice, F. L. (1998). Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. Journal of Acquired Immunodeficiency Syndrome and Human Retrovirology, 18, 341-348.
41. Myers, H. F., Satz, P., Miller, B. E., Bing, E. G., Evans, G., Richardson, M. A., et al. (1997). The African-American health project: Study overview and select findings on high risk behaviors and psychiatric disorders in African-American men. Ethnicity and Health, 2(3), 183-196.
42. O'Connor, P. G., & Samet, J. H. (1996). The substance using HIV patient: Approaches to outpatient management. American Journal of Medicine, 101, 435-444.
43. Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., et al. (1998). Declining morbidity and mortality among patients with advanced HIV infection. New England Journal of Medicine, 338, 853-860.
44. Paterson, D. L., & Swindells, S. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-30.
45. Peterson, J. L., Folkman, S., & Bakeman, R. (1996). Stress, coping, HIV status, psychosocial resources, and depressive mood in African-American gay, bisexual, and heterosexual men. American Journal of Community Psychology, 24(4), 461-487.
46. Reiter, G. S., Stewart, K. E., Wojusik, L., Hewitt, R., Segal-Maurer, S., Johnson, M., et al. (2000). Elements of success in HIV clinical care: Multiple interventions that promote adherence. Topics in HIV Medicine, 8, 21-30.
47. Roth, M. D., Tashkin, D. P., Choi, R., Jamieson, B. D., Zack, J. A., & Baldwin, G. C. (2002). Cocaine enhances human immunodeficiency virus replication: A model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes. Journal of Infectious Diseases, 185, 701-705.
48. Shapiro, M. F., Morton, S. C., McCaffrey, D. F., Senterfitt, J. W., Fleishman, J. A., Perlman, J. F., et al. (1999). Variations in the care of HIV-infected adults in the United States. Journal of the American Medical Association, 281, 2305-2315.
49. Sontag, S. (1997, March 17). Doctors withhold potent HIV treatments from some. New York Times, pp. 1A, 34A.
50. Stein, M. D., Piette, J., Mor, V., Wachtel, T. J., Fleishman, J., Mayer, K. H., et al. (1991). Differences in access to zidovudine (AZT) among symptomatic HIV infected person. Journal of General Internal Medicine, 6, 35-40.
51. Stone, V E. (2001). Strategies for optimizing adherence to highly active antiretroviral therapy (HAART). Clinical Infectious Diseases, 33(6), 855-872.
52. Stone, V E., Clarke, J., Lovell, J., Steger, K. A., Hirschhorn, L. R., Boswell, S., et al. (1998). HIV/AIDS patients' perspective on adhering to regimens containing protease inhibitors. Journal of General Internal Medicine, 13(9), 586-593.
53. Stone, V E., Mauch, M. Y., Steger, K., Janas, S. F., & Craven, D. E. (1997). Race, gender, drug use and participation in AIDS clinical trials: Lessons from a municipal hospital cohort. Journal of General Internal Medicine, 12, 150-157.
54. Stone, V E., Steger, K. A., Hirschorn, L. R., Boswell, S. L., Stein, M. D., Duefield, C. A., et al. (1998, June). Access to treatment with protease inhibitor (PI) containing regimens: Is it equal for all? Poster presented at the 12th World AIDS Conference, Geneva, Switzerland.
55. Stone, V E., Weissman, J. S., & Cleary, P. (1995). Satisfaction with ambulatory care of persons with AIDS: Predictors of patient ratings of quality. Journal of General Internal Medicine, 10, 239-245.
56. Thomas, S. B., & Quinn, S. C. (1991). The Tuskegee Syphilis Study, 1932 to 1972: Implications for HIV education and AIDS risk education programs in the Black community. American Journal of Public Health, 81, 1498-1504.
57. Turner, B. J. (2002). Adherence to antiretroviral therapy by human immunodeficiency virusinfected patients. Journal of Infectious Diseases, 185(2), S143-S151.
58. U.S. Department of Health & Human Services & the Henry J. Kaiser Family Foundation. (2002) Panel on clinical practices for treatment of HIV infection, guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Retrieved February 4, 2003, from http://aidsinfo.nih.gov or from the HIV/AIDS treatment information service at 1-800-448-10440
59. Valleroy, L., MacKellar, D. A., Karon, H. M., Rosen, D. H., McFarland, W., & Shehan, D. A. (2000). HIV prevalence and associated risks in young men who have sex with men. Journal of the American Medical Association, 284(2), 198-204.
60. Weissman, J. S., Makadon, H. I., Seage, G. R., Massagli, M. P., Gatsonis, C. A., Craven, D. E., et al. (1994). Changes in insurance status and access to care by persons with AIDS in the Boston Health Study. American Journal of Public Health, 84, 1997-2000.
61. Wingood, G., & DiClemente, R. J. (1992). Cultural, gender, and psychosocial influences on HIV- related behaviors of African-American female adolescents: Implications for the development of tailored prevention programs. Ethnicity and Disease, 2, 381-388.